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Abstract
Aims: To determine the value of echocardiography including tissue Doppler imaging (TDI) and right ventricular (RV) speckle
tracking analysis for the diagnosis of pulmonary hypertension (PH) and discrimination between pre- and postcapillary PH.
Methods and Results: 155 consecutive patients (mean age 70.5613.0 years, 81 [52%] male gender, BMI 27.266.1 kg/m
2)
with PH undergoing right heart catheterization (RHC) and transthoracic echocardiography (TTE) with TDI between January
2008 and December 2009 were retrospectively evaluated including offline speckle tracking analysis of RV contractility. After
RHC 23.2% of patients (36) were diagnosed with precapillary PH. Invasive results from RHC were significantly correlated to
TTE measurements (E/e ´, postcapillary wedge pressure [PCWP], r=0.61, P,0.001; mean, systolic pulmonary arterial pressure
[mPAP, sPAP], r=0.43, P,0.001). Single echocardiographic parameters were of good predictive value for final PH-diagnosis
(sPAP, area under the curve [AUC] 0.63, P=0.025; lateral apical RV longitudinal strain [RVaSl)], AUC 0.76, P=0.001; E/e ´, AUC
0.84, P,0.001) which could be increased by combining most predictive parameters after receiver operating curves (ROC)
cut off analysis (sPAP.69 mmHg, E/e ´,12, RVaSl $28.4%). TTE had a sensitivity of 33.33% and a specificity of 100% to
identify patients with precapillary PH, and a negative predictive value of 84.72% to rule out precapilary PH.
Conclusion: Echocardiography allows feasible and reliable estimation of PH and seems helpful to distinguish between pre-
and postcapillary PH. Further prospective studies on patients with different manifestations of PH must validate the
predictive value of echocardiography in this clinical setting.
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Introduction
Precapillary pulmonary arterial hypertension (PAH) is a severe
and life threatening disease, leading to death if untreated within 2–
3 years after diagnosis [1]. Definite diagnosis of PAH is often
delayed with a median of 3 years from onset of first symptoms to
start of effective therapy [2]. Therefore, current guidelines
emphasize the importance of early diagnosis of precapillary
PAH and differentiation from other entities of pulmonary
hypertension (PH) [3]. Up to now definite diagnosis of PAH can
only be confirmed by invasive right heart catheterization (RHC)
which is not widely available, puts the patients at risk for rare but
serious complications, and which is inconvenient for frequent
follow up evaluations [4]. Furthermore, PAH is a rare disease and
invasive RHC confirms postcapillary PH in most cases with
elevated pulmonary pressure. TTE is a non-invasive method
which is widely available, cost effective, and has been established
as non-invasive screening technique for the detection of PH.
Furthermore, echocardiographic studies are recommended at
regular intervals during the follow up of patients with proven PAH
under specific therapy [5]. It would be of great interest to identify
a simple, non-invasive diagnostic algorithm which allows for (a)
adequate PH diagnosis with a sufficient high reliability, and (b)
discriminates between pre-and postcapillary PH.
Therefore, we sought to determine the value of an echocardio-
graphic algorithm for the diagnosis of PH in patients with typical
clinical symptoms which were transferred to our hospital for
further evaluation.
Results
155 consecutive patients with PH undergoing standardized two
dimensional TTE before RHC between January 2008 and
December 2009 were analysed. Baseline characteristics as well as
results from RHC and TTE are presented in table 1. After RHC
36 (23.2%) patients were diagnosed with precapillary PH; in 119
(76.8%) patients PH was found to be postcapillary.
Echocardiographically determined sPAP was .30 mmHg in all
patients leading to a sensitivity of this parameter of 100% for the
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All patients
(n=155)
Precapillary
PH (n=36)
Postcapillary
PH (n=119) p-value
Age (years) 70.5613.0 65.9616.8 71.3611.4 0.002
BMI (kg/m
2) 27.266.1 26.266.0 27.666.4 0.37
Male gender (n, %) 81 (52%) 13 (36%) 68 (57%) 0.03
Hypertension (n, %) 91 (59%) 12 (36%) 78 (65%) 0.002
Diabetes mellitus (n, %) 33 (21%) 7 (19%) 26 (22%) 0.82
Smokers (n, %) 29 (19%) 7 (19%) 22 (18%) 1.0
Stroke (n, %) 3 (2%) 0 (0%) 3 (2%) 1.0
Lipid disorder (n, %) 45 (29%) 5 (14%) 40 (33%) 0.02
CAD (n, %) 80 (51%) 14 (39%) 66 (55%) 0.09
NYHA FC II (n, %) 28 (18%) 4 (11%) 24 (20%) 0.25
NYHA FC III (n, %) 93 (60%) 27 (75%) 66 (55%) 0.47
NYHA FC IV (n, %) 34 (22%) 5 (14%) 29 (24%) 0.31
Medication
Aspirin (n, %) 89 (57%) 17 (47%) 72 (60%) 0.18
ß-blocker (n, %) 115 (74%) 16 (44%) 99 (83%) ,0.0001
ARB/ACEI (n, %) 24 (15%) 3 (8%) 21 (18%) 0.29
Diuretics (n, %) 128 (83%) 23 (64%) 105 (88%) 0.002
Statin (n, %) 86 (55%) 14 (39%) 72 (60%) 0.03
CCB (n, %) 30 (19%) 8 (21%) 23 (19%) 1.0
OAC (n, %) 64 (41%) 12 (33%) 52 (44%) 0.33
Right heart catheterization
mPAP [mmHg] 38.7610.7 39.3613.3 38.569.8 0.70
sPAP [mmHg] 55.0617.6 60.3617.4 53.5617.4 0.04
CO [l/min] 3.663.8 3.262.3 3.464.2 0.42
PCWP [mmHg] 22.969.3 11.262.6 26.667.3 ,0.0001
RV systolic pressure [mmHg] 54.2620.1 58.1618.8 53.1620.5 0.18
RV diastolic pressure [mmHg] 5.365.8 4.365.8 5.665.8 0.24
RV mean pressure [mmHg] 9.468.6 11.9612.1 8.667.1 0.04
RA mean pressure [mmHg] 13.5613.1 12.765.4 13.8614.7 0.69
Echocardiography
sPAP [mmHg] 51.8617.1 58.3623.6 49.9614.2 0.009
LVEF [%] 53.2618.1 61.8613.9 50.6618.5 0.001
LAV [ml] 84.0652.7 79.9664.9 85.2648.7 0.6
RVDs [cm] 2.461.1 2.461.2 2.461.1 0.8
RVDd [cm] 3.361.4 3.461.6 3.361.3 0.88
E/e ´ 16.567.9 9.962.9 18.567.9 ,0.0001
MV E [m/s] 1.160.7 0.960.5 1.260.8 0.18
MV A [m/s] 0.660.5 0.660.5 0.660.5 0.77
MV e ´ [m/s] 0.0760.06 0.0760.04 0.0760.07 0.79
MV A [m/s] 0.0760.04 0.0760.04 0.0760.05 0.80
e ´/A 1.360.8 1.560.9 1.260.7 0.07
E/A 1.561.2 1.160.9 1.761.2 0.01
IVSd [cm] 1.260.6 1.160.3 1.360.6 0.08
2D RV longitudinal lateral apical strain [%] 28.064.6 5.763.4 210.464.5 0.003
BMI, body mass index; CAD, coronary artery disease; NYHA FC, NYHA functional class; CCB, calcium channel blocker; ARB/ACEI, angiotensin receptor blockers/
angiotensin converting enzyme inhibitor; mPAP, mean pulmonary arterial pressure; sPAP, systolic pulmonary arterial pressure; PCWP, pulmonary capillary wedge
pressure; RV, right ventricle; RA, right atrium; LVEF, left ventricular ejection fraction; E, early; A, atrial; MV, mitral velocity; RVDs/d, systolic/diastolic right ventricular
diameter; LAV, left atrial volume; IVSd, diastolic interventricular septum thickness.
doi:10.1371/journal.pone.0038519.t001
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discriminate pre-from postcapillary PH; its specificity was 0%.
When compared with results from RHC, non-invasive de-
termined sPAP was significantly correlated with invasively
measured mPAP (r=0.43; P,0.0001), but not with invasive sPAP
(r=0.15, P=0.06). PCWP values from RHC were significantly
correlated with TTE derived E/e ´ values (r=0.61, P,0.0001).
When comparing patient groups based on final PH diagnosis
several echocardiographic parameters and demographic parame-
ters showed significant differences (table 1). Patients with
precapillary PH tended to have a lower LV EF, lower E/e ´ values,
higher sPAP and higher RVaSl values. Mean values of invasively
measured sPAP (60.3617.4 mmHg vs. 53.5617.4 mmHg,
P=0.04) and sPAP derived from echocardiography
(58.3623.6 mmHg vs. 49.9614.2 mmHg, P=0.009) were signif-
icantly different in patients with precapillary and postcapillary PH.
Interestingly, only in patients with precapillary PH, there was
a significant correlation between invasive and non-invasive
measurements of sPAP-values (TTE: 58.3623.6 mmHg, RHC:
60.3617.4, mmHg; P=0.008; r=0.37), whereas in patients with
postcapillary PH this correlation was not found to be significant
(TTE: 49.9614.2 mmHg, RHC: 53.5617.4 mmHg; P=0.07;
r=0.15).
Echocardiographic Parameters Identifying Subjects with
Postcapillary PH.
When comparing groups with regard to invasive findings from
RHC only in patients with postcapillary PH a significant
correlation was found between PCWP and E/e (r=0.44,
P,0.001 vs. r=0.07, P=0.67), with increasing E/e values in
patients with postcapillary PH. ROC curve analysis confirmed the
predictive value of this parameter to identify patients with
postcapillary PH (AUC, 0.84, P,0.001) with an optimal cut off
value of .12. This parameter alone had a sensitivity of 78.69%
and specificity of 81.82%, a positive predictive value of 94.12%,
and a negative predictive value of 50.94% to identify patients with
postcapillary PH.
Echocardiographic Parameters Identifying Subjects with
Precapillary PH
Logistic stepwise backwards regression analysis of most pre-
dictive variables after univariate regression analysis (LV EF, E/A,
sPAP, E/e ´ and RVaSl) identified only E/e ´ (P=0.003) and RVaSl
(P=0.004) to be independently associated with the presence of
precapillary PH.
Figure 1. Incremental diagnostic value of apical strain and E/e ´ in addition to echocardiographically determined sPAP for
identification of patients with precapillary PH. AUC, area under the curve; CI, confidence interval; sPAP, systolic pulmonary arterial pressure; RVSl,
right ventricular longitudinal strain.
doi:10.1371/journal.pone.0038519.g001
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0.76, P=0.001; cut off value, .28.4%) with a sensitivity of
33.33% and a specificity of 95.08% of this parameter for the
identification of patients with precapillary PH.
When combining sPAP with RVaSl, TTE showed a sensitivity
of 88.24%, and specificity of 68.75% to identify patients with
precapillary PH. Finally, when adding sPAP to RVaSl and E/e ´ the
diagnostic value of echocardiography for the diagnosis of
precapillary PH showed a sensitivity of 33.33% and a specificity
of 100%, a positive predictive value of 100% and a negative
predictive value of 84.72% (figure 1).
Discussion
In our study we aimed to evaluate the diagnostic value of
echocardiography as non invasive screening method in patients
with suspected PH by using a simple algorithm which was
evaluated in a large cohort of symptomatic patients undergoing
non-invasive and invasive testing. The most important findings of
our study are that (a) estimation of PCWP with echocardiography
is feasible and of high value to identify subjects with postcapillary
PH and (b) echocardiography in combination with 2D speckle
tracking analysis of RV deformation capability has a high
predictive value to identify patients with precapillary PH.
Echocardiographic Parameters Predicting Postcapillary
PH
Hadano could show a relevant correlation of E/e ´ ratio with
PCWP and LVEDP, respectively in patients with heart failure
undergoing RHC which correlates with the results from our study.
However, this group did not investigate the diagnostic value of this
parameter in patients with suspected PH but without known
structural heart disease. [6,7].
More recently, Ruan and colleagues found normal or reduced
E/e ´ ratios in 70 patients with primary PH and increasing E/e ´
values in patients with PH due to cardiac aetiology were similarly
to the findings in our study group [8].
In contrast to this study group who suggested the use of lateral
mitral annulus systolic velocities [8] we used the average of septal
and lateral mitral annulus velocities as recommended by the
American and European society of echocardiography [9,10].
Additionally, we were able to show the high discriminative value of
E/e ´ to distinguish pre-from postcapillary PH in a considerably
larger patient group.
Echocardiographic Assessment of Patients with
Precapillary PH
Transthoracic echocardiography provides several different
variables which correlate well with right heart hemodynamics
and function, and therefore should always be performed in the
case of suspected PH [2]. However, up to now echocardiography
alone is considered inaccurate for the determination of pulmonary
arterial pressure in symptomatic subjects due to its limited
sensitivity and specificity [11] and, moreover, TTE is supposed
unable to differentiate between pre-and postcapillary PH, as
suggested in a recently published study by Bonderman et al. [12].
This group evaluated a non-invasive algorithm to exclude
precapillary pulmonary hypertension (PH) in 372 (251 retrospec-
tive, 121 prospective subjects) symptomatic patients with PH
combining echocardiography, ECG and laboratory testing (NT-
proBNP). In this study on highly selected patients the non-invasive
diagnostic algorithm including TTE had a good sensitivity of
100% and a low specificity of 19.3% for the detection of
precapillary PH [12].
In our study TTE derived sPAP did not correlate well with
sPAP from RHC. This finding may partly be explained by to the
fact that all patients underwent TTE $1 day before invasive
measurements and were fasting for at least 12 hours before
undergoing RHC leading to volume depletion and a decrease in
sPAP values. Importantly, invasive and non-invasive sPAP were
not significantly different in patients with precapillary PH
(60.3617.4 mmHg, 58.3623.6 mmHg, P=0.64), but in patient
with postcapillary PH after RHC (53.5617.4 mmHg,
49.8614.2 mmHg, P=0.04), indicating on a stronger volume-
load dependency of PAP in patients with postcapillary PH. These
finding supports current PH guidelines [2] suggesting a systemic
volume challenge in patients with suspected postcapillary PH
when invasive results are not decisive.
RV Strain Analysis in Patients with Pulmonary
Hypertension
Studies on 2D RV speckle tracking in patients with PH are
scarce. Ahmad et al. showed in 63 patients with different
aetiologies of RV impairment that 2D ST derived RV strain
correlated well with global RV function as determined with
cardiac magnetic resonance imaging (cMRI) [13].
In another study Fukuda and colleagues examined 45 patients
with precapillary PH and found RV free wall longitudinal strain
values to be of high diagnostic value of for the determination of
RV function before and after pharmacological treatment. In-
terestingly, in this study RV free wall longitudinal strain values was
highly significant correlated with changes in 6 minute walking
distance [14].
This is the first study to evaluate the value the combination of
non-invasive measurements for the estimation of PCWP, PAP, and
RVaSl to diagnose precapillary PH in symptomatic patients with
suspected PH. We found echocardiography to be of good
sensitivity and specificity for the detection of precapillary PH
and to be of reasonable good value to rule out precapillary PH
which is of great importance in this patient cohort.
Limitations
Our study cohort consisted of patients with invasively proven
PH. We did not follow a control group and our study design was
retrospective. However, our results indicate on a high reliability of
echocardiographic diagnostic in the setting of PH and suggest
a high reliability of this non invasive strategy for the differentiation
of pre-and postcapillary PH.
We did not evaluate the underlying aetiology of PAH or
postcapillary PH in this study. Sensitivity and specificity of this test
might not be the same in different patient groups with rare
aetiologies of PH. Therefore, further prospective studies on
different patients populations are required to confirm our findings.
Clinical Impact
RHC is often delayed in symptomatic patients with suspected
PH. Echocardiography provides reliable estimation of pulmonary
pressure and left ventricular filling pressures and is therefore
a valuable tool for the assessment of PH in clinical symptomatic
patients. Since the combination of sPAP, RVaSl and E/e ´ was of
high specificity to identify patients with precapillary PH, this non
invasive approach including RV speckle tracking analysis might be
an appropriate tool during the diagnostic work up of patients with
suspected PH.
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Echocardiography allows feasible and reliable estimation of PH
and seems helpful to distinguish between pre-and postcapillary
PH. Further prospective studies on patients with different
manifestations of PH must validate the predictive value of
echocardiography in this clinical setting.
Methods
Ethics Statement
The study has been approved by the ethics committee of the
University of Bonn. Informed consent was obtained by all patients
before study inclusion. Furthermore all the data were analyzed
anonymously. This study has been conducted according to the
principles expressed in the Declaration of Helsinki.
Study Concept
Figure 2 shows a flow chart of our study concept. Consecutive
patients with suspected PH undergoing standardized two di-
mensional TTE #7 days before RHC were retrospectively
analysed. Based on the invasive hemodynamic evaluation during
RHC, precapillary or postcapillary PH was diagnosed according
to current guidelines [3]. Patients with significant valvular heart
disease and cardiomyopathies of any aetiology were excluded from
the analysis. Precapillary PH was defined as mean pulmonary
arterial pressure (mPAP) $25 mmHg and pulmonary capillary
wedge pressure (PCWP) of #15 mmHg; patients with an Mpap
$25 mmHg and a PCWP .15 mmHg were defined as suffering
from postcapillary PH.
The following echocardiographic parameters were used to
evaluate the presence of PH and the concomitant finding of an
elevated PCWP which mainly distinguishes postcapillary PH from
precapillary PH.
Figure 2. Patient distribution according to results of right heart catheterization; flow chart of the study design. PH, postcapillary
pulmonary hypertension; RHC, right heart catheterization; TTE, transthoracic echocardiography; sPAP, systolic pulmonary arterial pressure; RVaSl, apical
right ventricular longitudinal strain.
doi:10.1371/journal.pone.0038519.g002
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continuous wave Doppler of systolic tricuspid regurgitant velocity
and considered elevated when reaching values .30 mmHg.
PCWP was assumed to be elevated (.15 mmHg) in cases with
E/e ´ ratio .12, a echocardiographic parameter which reflects on
left ventricular filling pressure and is defined as the ration of peak
mitral inflow velocities and peak mitral annulus velocity. Subjects
with sPAP.30 mmHg and E/e ´ ,12 were assumed to have
precapillary PAH, whereas in patients with sPAP.30 mmHg and
E/e ´ .12 PH was considered postcapillary. Furthermore, offline
speckle tracking (ST) analysis of right ventricular (RV) contractility
was performed in all subjects and compared with the results from
RHC aiming to determine the diagnostic value of this new
imaging technique in this clinical setting.
Transthoracic Echocardiography
Each patient underwent standardized two-dimensional trans-
thoracic echocardiography for the determination of left and right
ventricular functional parameters and dimensions according to the
recommendations of the American Society of Echocardiography
[15,16] using commercially available ultrasound scanner (Vivid 7,
General Electric Medical Health, Waukesha, Wisconsin, USA; iE
33, Philips Medical Systems, Koninklijke N.V.) with a 2.5-MHz
phased-array transducer. Echocardiographic views, including
apical four-and two-chamber views (4CV,2CV) and parasternal
(long-and short-axis views), with the patient in the left lateral
decubitus position, were obtained in two-dimensional, three-
dimensional and colour tissue Doppler imaging (TDI) modes. 2D
ejection fraction (EF) was calculated by Simpsons rule from 4 CV.
Mitral inflow velocities were recorded by standard pulsed-wave
Doppler at the tips of the mitral valve leaflets in an apical 4CV. E/
e ´ ratio was determined by measuring TDI derived systolic and
diastolic velocities of the septal and lateral mitral valve annulus
and averaging the values and conventional measurement of mitral
valve inflow velocities according to recommendations of the
American Society of Echocardiography [9]. During echo sPAP
was estimated by measuring the peak systolic tricuspid regurgitant
velocity flow at continuous wave Doppler if applicable.
2D Speckle Tracking Analysis of Right Ventricular
Deformation Capabilities
Figure 3 shows an example of RV ST analysis of RV
deformation capabilities. Two cine loops from apical four chamber
view were digitized and stored on an echocardiographic imaging
server (XCELERA, Philips Medical Systems, Koninklijke N.V.).
Offline 2D ST analyses of the gray scale images obtained by 2D
echocardiography were done by using commercially available
software (TomTec Imaging Systems GmbH, Unterschleissheim,
Germany). The endocardium of the free RV wall was manually
traced starting from the lateral tricuspidal annulus to RV apex,
and was tracked by the 2D strain software along the border
throughout two cardiac cycles. Accuracy of border tracking was
manually verified and adjusted if needed. The free right
ventricular wall was segmented visually in a basal, midventricular
and apical segment. For the determination of regional RV
impairment we followed the approach of Dambrauskaite [17]
and Lopez-Candalez [18]. Therefore only longitudinal lateral
apical RV Sl (RVaSl) entered further analysis. Of note, RV
speckle tracking analysis of free RV wall was applicable in all
patients.
Statistical Analysis
Exploratory data analysis was performed and no adjustment
was made for multiple tests.
Normal distribution of continuous variables was examined using
the Kolmogorov – Smirnov test. Continuous data was expressed as
mean values6standard deviation. Two-tailed P-values were
calculated and considered to be significant if ranging below
Figure 3. Right ventricular speckle tracking and 3 dimensional visualisation of longitudinal right ventricular strain values. Right
ventricular; 3D, three dimensional; RVSl, right ventricular longitudinal strain.
doi:10.1371/journal.pone.0038519.g003
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using students t test for paired samples or pair wise comparisons
with Wilcoxon signed rank test for paired continuous variables.
For categorical data Fisher’s exact test were calculated. Statistics
were performed using SPSS for Windows (PASW statistic.,
Version 17.0.2, SPSS Inc., Chicago, Illinois, USA) and MedCalc
statistical software (MedCalc Software, Version 11.4.1.0, Mar-
iakerke, Belgium).
To assess the predictive ability of the echocardiographic
parameters logistic regression was performed. Associated receiver
operating characteristic (ROC) curves for predicted probabilities
were drawn for a diagnostic model including sPAP, 2D RVaSl and
E/e ´. The corresponding areas under the curve along with their
95% CIs were calculated. Furthermore, we aimed to determine
the diagnostic value of single parameters, as well as the
combination of most predictive parameters for PH diagnosis by
calculating the sensitivity, specificity, negative and positive pre-
dictive values for each parameter and its combination.
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